BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21198574)

  • 1. "Mixing triptans": patient satisfaction.
    Rothrock JF; Morey V
    Headache; 2011 Jan; 51(1):135-40. PubMed ID: 21198574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiology of triptans in a headache centre.
    Ferrari A; Spaccapelo L; Sternieri E
    Cephalalgia; 2010 Jul; 30(7):847-54. PubMed ID: 20647176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
    Ng-Mak DS; Hu XH; Chen Y; Ma L; Solomon G
    Int J Clin Pract; 2007 Jul; 61(7):1091-111. PubMed ID: 17537184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-oral formulations of triptans and their use in acute migraine.
    Dahlöf CG
    Curr Pain Headache Rep; 2005 Jun; 9(3):206-12. PubMed ID: 15907260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
    Bigal M; Rapoport A; Aurora S; Sheftell F; Tepper S; Dahlof C
    Headache; 2007 Apr; 47(4):475-9. PubMed ID: 17445096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK; Banks J; Jones BA; Campbell J
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
    Headache; 2004; 44(7):661-8. PubMed ID: 15209687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part I: what do patients really need and want from migraine treatment?
    Gendolla A
    Curr Med Res Opin; 2005; 21 Suppl 3():S3-7. PubMed ID: 16083517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Triptans--pivotal event in migraine treatment].
    Lusić I; Bilić I
    Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
    Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK
    Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
    Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptans: low utilization and high turnover in the general population.
    Panconesi A; Pavone E; Franchini M; Mennuti N; Bartolozzi M; Guidi L; Banfi R
    Cephalalgia; 2010 May; 30(5):576-81. PubMed ID: 19732070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying the benefits of the AwM study in the clinic.
    Dodick DW
    Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute migraine treatment with oral triptans and NSAIDs in a managed care population.
    Ng-Mak DS; Hu XH; Chen YT; Ma L
    Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
    Burstein R; Collins B; Jakubowski M
    Ann Neurol; 2004 Jan; 55(1):19-26. PubMed ID: 14705108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptan therapy in migraine.
    Loder E
    N Engl J Med; 2010 Jul; 363(1):63-70. PubMed ID: 20592298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.